Randomized comparison of sirolimus eluting, and biolimus eluting bioresorbable polymer stents:the SORT-OUT VII optical coherence tomography study

Autor: Lars Jakobsen, Evald Høj Christiansen, Jakob Hjort, Lars Romer Krusell, Christian Juhl Terkelsen, Lisette Okkels Jensen, Anne Kaltoft, Steen Dalby Kristensen, Jens Flensted Lassen, Karsten Tange Veien, Niels Ramsing Holm, Jouke Dijkstra, Morten Madsen, Hans Erik Bøtker, Michael Maeng, Ida R. Balleby, Lene Nyhus Andreasen, Knud Nørregaard Hansen

Publikováno v: Andreasen, L N, Holm, N R, Balleby, I R, Krusell, L R, Mæng, M, Jakobsen, L, Veien, K T, Hansen, K N, Kristensen, S D, Hjort, J, Kaltoft, A, Dijkstra, J, Terkelsen, C J, Lassen, J F, Madsen, M, Bøtker, H E, Jensen, L O & Christiansen, E H 2018, ' Randomized comparison of sirolimus eluting, and biolimus eluting bioresorbable polymer stents : the SORT-OUT VII optical coherence tomography study ', European Heart Journal Cardiovascular Imaging, vol. 19, no. 3, pp. 329–338 . https://doi.org/10.1093/ehjci/jex035
Andreasen, L N, Holm, N R, Balleby, I R, Krusell, L R, Maeng, M, Jakobsen, L, Veien, K T, Hansen, K N, Kristensen, S D, Hjort, J, Kaltoft, A, Dijkstra, J, Terkelsen, C J, Lassen, J F, Madsen, M, Bøtker, H E, Jensen, L O & Christiansen, E H 2018, ' Randomized comparison of sirolimus eluting, and biolimus eluting bioresorbable polymer stents : the SORT-OUT VII optical coherence tomography study ', European Heart Journal Cardiovascular Imaging, vol. 19, no. 3, pp. 329-338 . https://doi.org/10.1093/ehjci/jex035

Aims: To show non-inferiority of the 67- or 87 µm thick, sirolimus-eluting Orsiro drug eluting stent (DES) to the 122 µm thick, biolimus-eluting Nobori DES regarding size of vessel lumen outside the stent at 13-month follow-up.Methods and results:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfa6b1aa27b8460d13c50a2d628bc013
https://portal.findresearcher.sdu.dk/da/publications/e74fb794-744e-4482-8a15-f399e18dea87

Activation of the phosphatidylinositol 3′-kinase/AKT pathway in neuroblastoma and its regulation by thioredoxin 1

Autor: Hervé Sartelet, Anne-Laure Rougemont, Raouf Fetni, Monique Fabre, Stefan Michiels, Gilles Vassal, Mona Beaunoyer, Michel Duval, M. Castaing

Publikováno v: Human Pathology, Vol. 42, No 11 (2011) pp. 1727-39

Neuroblastoma is a malignant pediatric tumor with poor survival. The phosphatidylinositol 3'-kinase/AKT pathway is a crucial regulator of cellular processes including apoptosis. Thioredoxin 1, an inhibitor of tumor-suppressor phosphatase and tensin h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c477b084fefee17b0cbe011943c0673b
https://doi.org/10.1016/j.humpath.2011.01.019

Renal function three years after early conversion from a calcineurin inhibitor to everolimus:results from a randomized trial in kidney transplantation

Autor: D. Solbu, Claus Bistrup, Helene Andersson, Bengt Gustafsson, Jesper Melchior Hansen, Bengt von zur Mühlen, Lars Mjörnstedt, Bente Jespersen, Søren Schwartz Sørensen, Hallvard Holdaas

Publikováno v: Mjörnstedt, L, Schwartz Sørensen, S, von Zur Mühlen, B, Jespersen, B, Hansen, J M, Bistrup, C, Andersson, H, Gustafsson, B, Solbu, D & Holdaas, H 2015, ' Renal function three years after early conversion from a calcineurin inhibitor to everolimus : results from a randomized trial in kidney transplantation ', Transplant International, vol. 28, no. 1, pp. 42-51 . https://doi.org/10.1111/tri.12437
Mjörnstedt, L, Schwartz Sørensen, S, von Zur Mühlen, B, Jespersen, B, Hansen, J M, Bistrup, C, Andersson, H, Gustafsson, B, Solbu, D & Holdaas, H 2015, ' Renal function three years after early conversion from a calcineurin inhibitor to everolimus : results from a randomized trial in kidney transplantation ', Transplant international : official journal of the European Society for Organ Transplantation, vol. 28, no. 1, pp. 42-51 . https://doi.org/10.1111/tri.12437

Summary In a 36-month, open-label, multicenter trial, 202 kidney transplant recipients were randomized at week 7 post-transplant to convert to everolimus or remain on cyclosporine: 182 were analyzed to month 36 (92 everolimus, 90 controls). Mean (SD)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8013f8d6ab68fef9f774244b1d482f32
https://pure.au.dk/portal/da/publications/renal-function-three-years-after-early-conversion-from-a-calcineurin-inhibitor-to-everolimus(73c44c36-9b03-44c7-a2b7-17fbda919257).html

Everolimus and sunitinib: from mouse models to treatment of pancreatic neuroendocrine tumors

Autor: Liakakos, T., Roukos, D. H.

Future Oncol

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10561::0b288e492c34202e3a7f9b80bb91b623
http://olympias.lib.uoi.gr/jspui/handle/123456789/21782

Anthropogenic factors and the risk of highly pathogenic avian influenza H5N1: prospects from a spatial-based model

Autor: Saraya Tavornpanich, Weerapong Thanapongtharm, Xiangming Xiao, Patrick Gasqui, François Roger, David Abrial, Myriam Charras-Garrido, Christian Ducrot, Mathilde Paul, Marius Gilbert

Publikováno v: Veterinary Research
Veterinary Research, BioMed Central, 2010, 41 (3), pp.28-42. ⟨10.1051/vetres/2009076⟩
Veterinary Research 3 (41), 28-42. (2010)
Veterinary research, 41 (3

Beginning in 2003, highly pathogenic avian influenza (HPAI) H5N1 virus spread across Southeast Asia, causing unprecedented epidemics. Thailand was massively infected in 2004 and 2005 and continues today to experience sporadic outbreaks. While researc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f571583cce3a4d4b600ad2a26a1b4c2c
https://hal.archives-ouvertes.fr/hal-00903153